Table 1

Participant characteristics by respondent

Respondent
AdolescentAdultOR or η2p ValueMothers*Fathers*OR or η2p Value
Sample size128647393127975
Age, mean (SD), years14.84 (1.69)28.87 (9.54)0.32<0.0018.90 (5.08)8.52 (5.14)<0.010.040
Female (%)669 (53)2271 (48)1.140.0441558 (50)460 (47)1.140.075
BMI, mean (SD)19.54 (3.11)21.87 (3.54)0.07<0.00117.47 (2.99)17.28 (2.92)<0.010.102
FEV1 percent predicted, mean (SD)83.78 (23.44)62.32 (24.51)0.12<0.0189.23 (21.55)90.74 (22.13)<0.010.112
Haemoptysis or pneumothorax in 6 months (%)35 (3)657 (14)0.21<0.00137 (1)9 (1)0.980.969
Currently on intravenous antibiotics (%)156 (12)733 (16)0.50<0.001299 (10)118 (12)1.220.146
Listed for transplant (%)7 (1)243 (5)0.09<0.00112 (0.4)1 (0.1)
Currently on psychiatric medication for depression/anxiety (%)44 (4)466 (10)0.29<0.00159 (2)9 (0.9)1.950.231
Currently receiving psychotherapy for depression/anxiety (%)70 (6)379 (8)0.630.001103 (3)19 (2)1.230.526
Positive scores (%)Caregivers
HADS-D60 (5)609 (13)0.30<0.001618 (20)173 (18)1.150.142
CES-D87 (19)488 (29)0.53<0.0011057 (34)240 (25)1.58<0.001
Either HADS-D or CES-D130 (10)913 (19)0.39<0.0011165 (37)305 (31)1.34<0.001
HADS-A281 (22)1503 (32)0.60<0.0011496 (48)343 (36)1.70<0.001
  • *Characteristics of younger patients whose parents completed the screening. The amount of variability across strata was estimated using η2 for continuous variables. ORs comparing younger with older participants and Mothers with Fathers, were used to index the size of the differences between the strata.

  • HADS, Hospital Anxiety and Depression Scale; CES-D, Center for Epidemiologic Studies-Depression Scale; BMI, body mass index.